U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C28H27NO2S
Molecular Weight 441.584
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of HX-630

SMILES

CC1(C)CCC(C)(C)C2=C1C=C3SC4=CC=CC=C4N=C(C5=CC=C(C=C5)C(O)=O)C3=C2

InChI

InChIKey=PFGCWQPTOKPRRK-UHFFFAOYSA-N
InChI=1S/C28H27NO2S/c1-27(2)13-14-28(3,4)21-16-24-19(15-20(21)27)25(17-9-11-18(12-10-17)26(30)31)29-22-7-5-6-8-23(22)32-24/h5-12,15-16H,13-14H2,1-4H3,(H,30,31)

HIDE SMILES / InChI

Molecular Formula C28H27NO2S
Molecular Weight 441.584
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/26714014 https://www.ncbi.nlm.nih.gov/pubmed/24916544

HX630 is a synthetic RXR pan-agonist. HX-630 has bein shown to exert anti-proliferative and pro-apoptotic effects in murine pituitary corticotroph tumor AtT20 cells, making HX-630 a new therapeutic candidate for Cushing’s disease. It might also serve as potential pharmacological tool for treating retina degenerative diseases and Alzheimer's disease.

Approval Year

TargetsConditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Patents

Patents

Sample Use Guides

Mice: 5 mg/kg/day, injected intraperitonealy 3 times a week for 3 weeks
Route of Administration: Intraperitoneal
HX-630 significantly suppressed AtT20 cell proliferation at 10 uμM
Substance Class Chemical
Created
by admin
on Sat Dec 16 09:00:08 GMT 2023
Edited
by admin
on Sat Dec 16 09:00:08 GMT 2023
Record UNII
N564S742U1
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
HX-630
Common Name English
BENZOIC ACID, 4-(7,8,9,10-TETRAHYDRO-7,7,10,10-TETRAMETHYLBENZO(B)NAPHTHO(2,3-F)(1,4)THIAZEPIN-12-YL)-
Systematic Name English
Code System Code Type Description
CAS
188844-52-2
Created by admin on Sat Dec 16 09:00:08 GMT 2023 , Edited by admin on Sat Dec 16 09:00:08 GMT 2023
PRIMARY
EPA CompTox
DTXSID80172254
Created by admin on Sat Dec 16 09:00:08 GMT 2023 , Edited by admin on Sat Dec 16 09:00:08 GMT 2023
PRIMARY
PUBCHEM
9889522
Created by admin on Sat Dec 16 09:00:08 GMT 2023 , Edited by admin on Sat Dec 16 09:00:08 GMT 2023
PRIMARY
FDA UNII
N564S742U1
Created by admin on Sat Dec 16 09:00:08 GMT 2023 , Edited by admin on Sat Dec 16 09:00:08 GMT 2023
PRIMARY
Related Record Type Details
ACTIVE MOIETY